159 related articles for article (PubMed ID: 31285548)
1. Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions.
Marcus J; Bejerano-Sagie M; Patterson N; Bagchi S; Verkhusha VV; Connolly D; Goldberg GL; Golden A; Sharma VP; Condeelis J; Montagna C
Oncogene; 2019 Jul; 38(30):5839-5859. PubMed ID: 31285548
[TBL] [Abstract][Full Text] [Related]
2. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
3. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
[TBL] [Abstract][Full Text] [Related]
4. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.
Devlin L; Okletey J; Perkins G; Bowen JR; Nakos K; Montagna C; Spiliotis ET
Proteomics; 2021 Oct; 21(19):e2100155. PubMed ID: 34409731
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.
Gonzalez ME; Makarova O; Peterson EA; Privette LM; Petty EM
Cell Signal; 2009 Apr; 21(4):477-87. PubMed ID: 19071215
[TBL] [Abstract][Full Text] [Related]
7. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
[TBL] [Abstract][Full Text] [Related]
8. Septins promote stress fiber-mediated maturation of focal adhesions and renal epithelial motility.
Dolat L; Hunyara JL; Bowen JR; Karasmanis EP; Elgawly M; Galkin VE; Spiliotis ET
J Cell Biol; 2014 Oct; 207(2):225-35. PubMed ID: 25349260
[TBL] [Abstract][Full Text] [Related]
9. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
[TBL] [Abstract][Full Text] [Related]
10. Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms.
Iv F; Martins CS; Castro-Linares G; Taveneau C; Barbier P; Verdier-Pinard P; Camoin L; Audebert S; Tsai FC; Ramond L; Llewellyn A; Belhabib M; Nakazawa K; Di Cicco A; Vincentelli R; Wenger J; Cabantous S; Koenderink GH; Bertin A; Mavrakis M
J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34350965
[TBL] [Abstract][Full Text] [Related]
11. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Hancox RA; Allen MD; Holliday DL; Edwards DR; Pennington CJ; Guttery DS; Shaw JA; Walker RA; Pringle JH; Jones JL
Breast Cancer Res; 2009; 11(2):R24. PubMed ID: 19405959
[TBL] [Abstract][Full Text] [Related]
12. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.
Montagna C; Lyu MS; Hunter K; Lukes L; Lowther W; Reppert T; Hissong B; Weaver Z; Ried T
Cancer Res; 2003 May; 63(9):2179-87. PubMed ID: 12727837
[TBL] [Abstract][Full Text] [Related]
13. The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts.
Hecht M; Alber N; Marhoffer P; Johnsson N; Gronemeyer T
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38719752
[TBL] [Abstract][Full Text] [Related]
14. An oncogenic isoform of septin 9 promotes the formation of juxtanuclear invadopodia by reducing nuclear deformability.
Okletey J; Angelis D; Jones TM; Montagna C; Spiliotis ET
Cell Rep; 2023 Aug; 42(8):112893. PubMed ID: 37516960
[TBL] [Abstract][Full Text] [Related]
15. Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.
Rubashkin MG; Cassereau L; Bainer R; DuFort CC; Yui Y; Ou G; Paszek MJ; Davidson MW; Chen YY; Weaver VM
Cancer Res; 2014 Sep; 74(17):4597-611. PubMed ID: 25183785
[TBL] [Abstract][Full Text] [Related]
16. SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission.
Kim MS; Froese CD; Estey MP; Trimble WS
J Cell Biol; 2011 Nov; 195(5):815-26. PubMed ID: 22123865
[TBL] [Abstract][Full Text] [Related]
17. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
Vardi-Oknin D; Golan M; Mabjeesh NJ
PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
[TBL] [Abstract][Full Text] [Related]
18. Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.
Sellin ME; Stenmark S; Gullberg M
Mol Biol Cell; 2012 Nov; 23(21):4242-55. PubMed ID: 22956766
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.
Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
Zhang G; Feng W; Wu J
Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
